Evidence map›Paper›PMID 26015774›Full record

ArticlePostepy dermatologii i alergologii2015

Follow-up of patients with mycosis fungoides after interferon α2b treatment failure.

Ewa Chmielowska, Maciej Studziński, Sebastian Giebel, Anna Krause, Monika Olejniczak, Aleksandra Grzanka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Postepy dermatologii i alergologii, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Primary cutaneous lymphomas: diagnosis and treatment.Postepy dermatologii i alergologii · 2015
    Review
  3. Mycosis fungoides: therapeutic difficulties.Postepy dermatologii i alergologii · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ewa ChmielowskaClinical Oncology Department, Oncology Center, Bydgoszcz, Poland. Head of the Department: Ewa Chmielowska MD, PhD.
Maciej StudzińskiClinic of Oncology and Brachytherapy, Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Poland. Head of the Department: Prof. Roman Makarewicz MD, PhD.
Sebastian GiebelDepartment of Bone Marrow Transplantation and Hematooncology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Poland. Head of the Department: Prof. Sebastian Giebel.
Anna KrauseClinical Oncology Department, Oncology Center, Bydgoszcz, Poland. Head of the Department: Ewa Chmielowska MD, PhD.
Monika OlejniczakClinical Oncology Department, Oncology Center, Bydgoszcz, Poland. Head of the Department: Ewa Chmielowska MD, PhD.
Aleksandra GrzankaDepartment of Dermatology, Univeristy Hosptal No. 1, Bydgoszcz, Poland. Head of the Department: Rafal Czajkowski MD, PhD.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTreatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low.

aimReport of single center experience of management CTCL after progression after first line treatment. MATERIAL AND

methodsWe present 41 patients with CTCL, 29 received interferon α2b in first line, and 12 of them received second line therapy.

resultsOverall response rate for second line therapy was 60%.

conclusionsResults of the follow-up of patients with mycosis fungoides after interferon α2b treatment failure with the literature review and discussion.

Indexed as

chemotherapyinterferonmycosis fungoides

Identifiers

PMID26015774
PMCPMC4436229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.